Andrea Ardizzoni
Impact in
- Oncology top 0.1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 336
- Lung Cancer Research Studies 144
- Cancer Immunotherapy and Biomarkers 83
- Colorectal Cancer Treatments and Studies 49
- HER2/EGFR in Cancer Research 39
-
- Lung Cancer Treatments and Mutations 200
- Lung Cancer Diagnosis and Treatment 47
- Co-authors
- Marcello Tiseo (108 shared papers)Francesco Gelsomino (65 shared papers)Giuseppe Giaccone (22 shared papers)Beatrice Bortesi (21 shared papers)Antonino Musolino (19 shared papers)Luca Boni (30 shared papers)Nico van Zandwijk (13 shared papers)Nadia Naldi (18 shared papers)
- Journals
- Lung Cancer (48 papers)Annals of Oncology (41 papers)Journal of Clinical Oncology (32 papers)Journal of Thoracic Oncology (29 papers)European Journal of Cancer (17 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Andrea Ardizzoni
459 papers receiving 12.8k citations
Andrea Ardizzoni's Hit Papers
Peers
Comparison fields: 5 of 134
- Oncology 8.4k
- Pulmonary and Respiratory Medicine 6.6k
- Cancer Research 1.6k
- Epidemiology 2.0k
- Radiology, Nuclear Medicine and Imaging 1.3k
Countries citing papers authored by Andrea Ardizzoni
This map shows the geographic impact of Andrea Ardizzoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Ardizzoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Ardizzoni more than expected).
Fields of papers citing papers by Andrea Ardizzoni
This network shows the impact of papers produced by Andrea Ardizzoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Ardizzoni. The network helps show where Andrea Ardizzoni may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrea Ardizzoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 471 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer Hit paper breakdown → | 2008 | 745 |
| 2 | 2007 | 464 | |
| 3 | 1997 | 377 | |
| 4 | Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial Hit paper breakdown → | 2015 | 324 |
| 5 | Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Hit paper breakdown → | 2021 | 321 |
| 6 | 2003 | 298 | |
| 7 | 2007 | 274 | |
| 8 | 2002 | 219 | |
| 9 | 2005 | 155 | |
| 10 | 2013 | 146 | |
| 11 | 1996 | 143 | |
| 12 | 2017 | 132 | |
| 13 | 2017 | 126 | |
| 14 | 2004 | 121 | |
| 15 | 2020 | 116 | |
| 16 | 2011 | 116 | |
| 17 | 2010 | 113 | |
| 18 | 1999 | 109 | |
| 19 | 2020 | 109 | |
| 20 | 2020 | 107 |
About Andrea Ardizzoni
Andrea Ardizzoni is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Cancer Research, having authored 471 papers that have together received 13.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (200 papers), Lung Cancer Research Studies (144 papers), Cancer Immunotherapy and Biomarkers (83 papers), Cancer therapeutics and mechanisms (56 papers), Colorectal Cancer Treatments and Studies (49 papers), Neuroendocrine Tumor Research Advances (48 papers), Lung Cancer Diagnosis and Treatment (47 papers) and HER2/EGFR in Cancer Research (39 papers). The work is most often cited by research in Oncology (8.4k citations), Pulmonary and Respiratory Medicine (6.6k citations), Cancer Research (1.6k citations), Epidemiology (2.0k citations) and Radiology, Nuclear Medicine and Imaging (1.3k citations). Andrea Ardizzoni has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Marcello Tiseo, Francesco Gelsomino, Giuseppe Giaccone, Beatrice Bortesi, Antonino Musolino, Luca Boni, Nico van Zandwijk, Nadia Naldi, Roberta Camisa and Marzia Capelletti. Their work appears in journals such as Lung Cancer, Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.